Pathological Aging of the Brain: An Overview
暂无分享,去创建一个
Frederik Barkhof | Philip Scheltens | P. Scheltens | F. Barkhof | A. B. Bastos Leite | António J Bastos Leite
[1] M. Oda,et al. Progressive supranuclear palsy: MRI and pathological findings , 1996, Neuroradiology.
[2] B. Drayer,et al. Imaging of the Aging Brain , 2005 .
[3] G. Frisoni,et al. Structural correlates of early and late onset Alzheimer’s disease: voxel based morphometric study , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[4] P. Scheltens,et al. Impact of Age-Related Cerebral White Matter Changes on the Transition to Disability – The LADIS Study: Rationale, Design and Methodology , 2004, Neuroepidemiology.
[5] Nick C Fox,et al. Pathological substrate for regional distribution of increased atrophy rates in progressive supranuclear palsy , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[6] S. Gauthier,et al. Treatment of vascular dementia—evidence from clinical trials with cholinesterase inhibitors , 2004, Journal of the Neurological Sciences.
[7] F Barkhof,et al. Enlarged Virchow-Robin spaces: do they matter? , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[8] Alan A. Wilson,et al. In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET. , 2004, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[9] Karen J. Ferguson,et al. Enlarged perivascular spaces are associated with cognitive function in healthy elderly men , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[10] E G Tangalos,et al. 1H MR spectroscopy in common dementias , 2004, Neurology.
[11] Nick C. Fox,et al. Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease , 2004, NeuroImage.
[12] Agneta Nordberg,et al. PET imaging of amyloid in Alzheimer's disease , 2004, The Lancet Neurology.
[13] M. F. Falangola,et al. Visualization of β‐amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents , 2004, Magnetic resonance in medicine.
[14] M. Citron,et al. Strategies for disease modification in Alzheimer's disease , 2004, Nature Reviews Neuroscience.
[15] Huali Wang,et al. Prolongation of T2 relaxation times of hippocampus and amygdala in Alzheimer's disease , 2004, Neuroscience Letters.
[16] Matthias J. Müller,et al. Ultrastructural Hippocampal and White Matter Alterations in Mild Cognitive Impairment: A Diffusion Tensor Imaging Study , 2004, Dementia and Geriatric Cognitive Disorders.
[17] A. Haley,et al. Shortening of hippocampal spin-spin relaxation time in probable Alzheimer's disease: a 1H magnetic resonance spectroscopy study , 2004, Neuroscience Letters.
[18] M. O’Sullivan,et al. Diffusion tensor imaging of thalamus correlates with cognition in CADASIL without dementia , 2004, Neurology.
[19] W. Klunk,et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.
[20] C. Jack,et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD , 2004, Neurology.
[21] H S Markus,et al. Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[22] P. Scheltens,et al. Thalamic Lesions in Vascular Dementia: Low Sensitivity of Fluid-Attenuated Inversion Recovery (FLAIR) Imaging , 2004, Stroke.
[23] G K Wenning,et al. Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[24] P. Scheltens,et al. Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: Interobserver reliability , 1995, Journal of Neurology.
[25] P. Jolles,et al. An in vitro 1H nuclear magnetic resonance study of the temporoparietal cortex of Alzheimer brains , 2004, Experimental Brain Research.
[26] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[27] P. Doraiswamy,et al. In vivo amyloid imaging in Alzheimer’s disease , 2004, Neuroradiology.
[28] I G McKeith,et al. Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer’s disease , 2003, Neurology.
[29] Sung-Cheng Huang,et al. 2-Dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer's disease. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.
[30] F Barkhof,et al. Identifying confounds to increase specificity during a “no task condition” Evidence for hippocampal connectivity using fMRI , 2003, NeuroImage.
[31] Nick C Fox,et al. Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC , 2003, Journal of neurology, neurosurgery, and psychiatry.
[32] J. Barrio,et al. Molecular-Imaging Probe 2-(1-{6-[(2-Fluoroethyl)(Methyl) Amino]-2-Naphthyl}Ethylidene) Malononitrile Labels Prion Plaques In Vitro , 2003, The Journal of Neuroscience.
[33] Atsuo Tanaka,et al. High b value diffusion-weighted imaging is more sensitive to white matter degeneration in Alzheimer's disease , 2003, NeuroImage.
[34] Frederik Barkhof,et al. Operational Definitions for the NINDS-AIREN Criteria for Vascular Dementia: An Interobserver Study , 2003, Stroke.
[35] Maria Assunta Rocca,et al. Evidence of subtle gray-matter pathologic changes in healthy elderly individuals with nonspecific white-matter hyperintensities. , 2003, Archives of neurology.
[36] Thomas Wisniewski,et al. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging , 2003, Magnetic resonance in medicine.
[37] Eric E. Smith,et al. Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria , 2003, Current atherosclerosis reports.
[38] F Barkhof,et al. Loss of frontal fMRI activation in early frontotemporal dementia compared to early AD , 2003, Neurology.
[39] W. M. van der Flier,et al. Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease , 2003, Neurology.
[40] Clifford R Jack,et al. Neuroimaging in Alzheimer disease: an evidence-based review. , 2003, Neuroimaging clinics of North America.
[41] G. Román,et al. Vascular Dementia: Distinguishing Characteristics, Treatment, and Prevention , 2003, Journal of the American Geriatrics Society.
[42] J. Baron,et al. Mild cognitive impairment , 2003, Neurology.
[43] M. Emre. Dementia associated with Parkinson's disease , 2003, The Lancet Neurology.
[44] Emma J. Burton,et al. A comprehensive study of gray matter loss in patients with Alzheimer’s disease using optimized voxel-based morphometry , 2003, NeuroImage.
[45] R. Coleman,et al. Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. , 2003, Radiology.
[46] Jean-Claude Baron,et al. Early diagnosis of alzheimer’s disease: contribution of structural neuroimaging , 2003, NeuroImage.
[47] Nick C Fox,et al. Computer-assisted imaging to assess brain structure in healthy and diseased brains , 2003, The Lancet Neurology.
[48] K. Jellinger,et al. The pathology of ischemic-vascular dementia An update , 2002, Journal of the Neurological Sciences.
[49] Thomas Wisniewski,et al. Molecular Targeting of Alzheimer's Amyloid Plaques for Contrast-Enhanced Magnetic Resonance Imaging , 2002, Neurobiology of Disease.
[50] M. Kameyama,et al. White Matter Lesions and Dementia MRI‐Pathological Correlation , 2002, Annals of the New York Academy of Sciences.
[51] E. Tangalos,et al. Comparative Diagnostic Utility of Different MR Modalities in Mild Cognitive Impairment and Alzheimer’s Disease , 2002, Dementia and Geriatric Cognitive Disorders.
[52] H. Chui,et al. Subcortical ischaemic vascular dementia , 2002, The Lancet Neurology.
[53] Kevin M Bradley,et al. Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease. , 2002, Brain : a journal of neurology.
[54] W. M. van der Flier,et al. Cognitive decline in AD and mild cognitive impairment is associated with global brain damage , 2002, Neurology.
[55] et al.,et al. Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET , 2002, NeuroImage.
[56] S. Blackband,et al. MR microscopy and high resolution small animal MRI: applications in neuroscience research , 2002, Progress in Neurobiology.
[57] J. O'Brien,et al. A Comprehensive Review of Proton Magnetic Resonance Spectroscopy Studies in Dementia and Parkinson’s Disease , 2002, Dementia and Geriatric Cognitive Disorders.
[58] N. Schuff,et al. Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus , 2002, Neurology.
[59] A. Vighetto,et al. Thalamic venous infarction as a cause of subacute dementia. , 2002, Neurology.
[60] Frederik Barkhof,et al. Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion , 2002, The Lancet Neurology.
[61] Ocular apraxia in recessive ataxia. , 2002, Archives of neurology.
[62] Regional N-acetylaspartate reduction in the hippocampus detected with fast proton magnetic resonance spectroscopic imaging in patients with Alzheimer disease. , 2002, Archives of neurology.
[63] P. Scheltens,et al. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment , 2002, Journal of neurology, neurosurgery, and psychiatry.
[64] N. Schuff,et al. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD , 2002, Neurology.
[65] Masatoshi Itoh,et al. Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease. , 2002, The American journal of psychiatry.
[66] D. Prayer,et al. Sequential MRI in a case of Creutzfeldt-Jakob disease , 2002, Neuroradiology.
[67] Hirofumi Sakurai,et al. Atrophy of the substantia innominata on magnetic resonance imaging and response to donepezil treatment in Alzheimer's disease , 2002, Neuroscience Letters.
[68] PhD Jaap Valk MD,et al. Magnetic Resonance in Dementia , 2002, Springer Berlin Heidelberg.
[69] K. Jellinger. Vascular-ischemic dementia: an update. , 2002, Journal of neural transmission. Supplementum.
[70] M. Kraut,et al. Diffusion tensor MR imaging of the brain and white matter tractography. , 2002, AJR. American journal of roentgenology.
[71] G. Small,et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[72] F Aichner,et al. Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI. , 2002, Neurology.
[73] F. Träber,et al. In-vivo proton MR-spectroscopy of the human brain: Assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration , 2002, Amino Acids.
[74] H. Hanyu,et al. MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia. , 2002, AJNR. American journal of neuroradiology.
[75] Charles DeCarli,et al. Radial width of the temporal horn: a sensitive measure in Alzheimer disease. , 2002, AJNR. American journal of neuroradiology.
[76] N. Schuff,et al. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer’s disease , 2001, Neurology.
[77] G. Alexander,et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. , 2001, JAMA.
[78] N. Schuff,et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.
[79] W. Bradley. Normal pressure hydrocephalus and deep white matter ischemia: which is the chicken, and which is the egg? , 2001, AJNR. American journal of neuroradiology.
[80] M. Ferrari,et al. Cerebral microbleeds in CADASIL , 2001, Neurology.
[81] F. Jessen,et al. Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients , 2001, Neurology.
[82] A. Colchester,et al. MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. , 2001, Clinical radiology.
[83] M. Bobinski,et al. Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[84] Nick C Fox,et al. Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images , 2001, The Lancet.
[85] H. Hanyu,et al. Magnetization transfer measurements of the hippocampus in the early diagnosis of Alzheimer's disease , 2001, Journal of the Neurological Sciences.
[86] H. Hanyu,et al. Magnetisation transfer measurements of the subcortical grey and white matter in Parkinson's disease with and without dementia and in progressive supranuclear palsy , 2001, Neuroradiology.
[87] L Solymosi,et al. Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. , 2001, Archives of neurology.
[88] A. Compston,et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.
[89] J. Hardy,et al. Prevalence of Alzheimer’s disease in very elderly people , 2001, Neurology.
[90] A E George,et al. What role does functional MR imaging play in the diagnosis or prediction of future-onset Alzheimer's disease? , 2001, AJNR. American journal of neuroradiology.
[91] R. Floris,et al. Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load. , 2001, AJNR. American journal of neuroradiology.
[92] J. Hodges. Frontotemporal dementia (Pick’s disease): Clinical features and assessment , 2001, Neurology.
[93] J T O'Brien,et al. Combined Magnetic Resonance Imaging and Single-Photon Emission Tomography Scanning in the Discrimination of Alzheimer's Disease From Age-Matched Controls , 2001, International Psychogeriatrics.
[94] G. Frisoni,et al. Structural imaging in the clinical diagnosis of Alzheimer's disease: problems and tools , 2001, Journal of neurology, neurosurgery, and psychiatry.
[95] P. Scheltens,et al. A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT , 2001, Stroke.
[96] E. Tangalos,et al. CME Practice parameter: , 2022 .
[97] B. Miller,et al. CME Practice parameter : Diagnosis of dementia ( an evidence-based review ) Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2001 .
[98] T. Erkinjuntti. Clinical deficits of Alzheimer's disease with cerebrovascular disease and probable VaD. , 2001, International journal of clinical practice. Supplement.
[99] R. V. Van Heertum,et al. SPECT perfusion imaging in the diagnosis of Alzheimer’s disease , 2001, Neurology.
[100] C. Jack,et al. Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. , 2001, Radiology.
[101] B L Miller,et al. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. , 2001, Archives of neurology.
[102] J D Fenwick,et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD , 2001, Neurology.
[103] P Sachdev,et al. Magnetic resonance spectroscopy in AD , 2001, Neurology.
[104] K. Ishii,et al. Occipital Glucose Metabolism in Dementia with Lewy Bodies with and without Parkinsonism: A Study Using Positron Emission Tomography , 2001, Dementia and Geriatric Cognitive Disorders.
[105] M N Rossor,et al. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease , 2001, Annals of neurology.
[106] C Gössl,et al. Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. , 2001, Radiology.
[107] Ian G. McKeith,et al. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales , 2001, The Lancet.
[108] Murat Emre,et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study , 2000, The Lancet.
[109] M W Weiner,et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease , 2000, Neurology.
[110] A. Kertesz,et al. The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia , 2000, Neurology.
[111] L. Defebvre,et al. Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to 99mTc HmPAO SPECT data , 2000, Journal of neurology, neurosurgery, and psychiatry.
[112] M. Witter,et al. Functional MR imaging in Alzheimer's disease during memory encoding. , 2000, AJNR. American journal of neuroradiology.
[113] P Julin,et al. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study , 2000, Journal of neurology, neurosurgery, and psychiatry.
[114] F. Tison,et al. Oral zolmitriptan is effective in the acute treatment of cluster headache , 2000, Neurology.
[115] S. Rose,et al. Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging , 2000, Journal of neurology, neurosurgery, and psychiatry.
[116] E. Mori. [Dementia with Lewy bodies]. , 2000, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.
[117] K. Marder,et al. The Role of Routine Laboratory Studies and Neuroimaging in the Diagnosis of Dementia: A Clinicopathological Study , 2000, Journal of the American Geriatrics Society.
[118] W. Bradley,et al. Normal pressure hydrocephalus: new concepts on etiology and diagnosis. , 2000, AJNR. American journal of neuroradiology.
[119] F Träber,et al. Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD , 2000, Neurology.
[120] H. Gertz,et al. Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study , 2000, International journal of geriatric psychiatry.
[121] Mark S. Cohen,et al. Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.
[122] Anders Wallin,et al. Frontotemporal Dementia Can Be Distinguished from Alzheimer’s Disease and Subcortical White Matter Dementia by an Anterior-to-Posterior rCBF-SPET Ratio , 2000, Dementia and Geriatric Cognitive Disorders.
[123] H. Braak,et al. Sequence of Aβ‐Protein Deposition in the Human Medial Temporal Lobe , 2000 .
[124] Patrick R. Hof,et al. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.
[125] E G Tangalos,et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease , 2000, Neurology.
[126] K. Jellinger. Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia , 2000, Journal of neurology, neurosurgery, and psychiatry.
[127] J. Saver,et al. Endovascular treatment of dural sinus thrombosis with rheolytic thrombectomy and intra-arterial thrombolysis. , 2000, Stroke.
[128] G. Frisoni,et al. Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer’s disease: a morphometric MRI study , 2000, Biological Psychiatry.
[129] Karl J. Friston,et al. Voxel-Based Morphometry—The Methods , 2000, NeuroImage.
[130] C. Jack,et al. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD , 2000, Neurology.
[131] James W Ironside,et al. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease , 2000, The Lancet.
[132] Elna-Marie Larsson,et al. Magnetic Resonance Imaging and Histopathology in Dementia, Clinically of Frontotemporal Type , 2000, Dementia and Geriatric Cognitive Disorders.
[133] P. Scheltens,et al. Preliminary Results from an MRI/CT‐Based Database for Vascular Dementia and Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.
[134] M. Esiri. Which Vascular Lesions Are of Importance in Vascular Dementia? , 2000, Annals of the New York Academy of Sciences.
[135] I G McKeith,et al. MRI volumetric study of dementia with Lewy bodies , 2000, Neurology.
[136] R. Anand,et al. An efficacy and safety analysis of Exelon® in Alzheimer’s disease patients with concurrent vascular risk factors , 2000, European journal of neurology.
[137] C. Jack,et al. Memory and MRI-based hippocampal volumes in aging and AD , 2000, Neurology.
[138] V. Hachinski,et al. Prevalence and outcomes of vascular cognitive impairment , 2000, Neurology.
[139] J. Adair,et al. Diffusion-weighted MRI in vascular dementia , 2000, Neurology.
[140] J. Detre,et al. Assessment of cerebral blood flow in Alzheimer's disease by spin‐labeled magnetic resonance imaging , 2000, Annals of neurology.
[141] G C Roman,et al. Research criteria for subcortical vascular dementia in clinical trials. , 2000, Journal of neural transmission. Supplementum.
[142] The incidence of dementia in Canada. The Canadian Study of Health and Aging Working Group. , 2000, Neurology.
[143] M. Grisoli,et al. Magnetic resonance imaging in CBD, related atypical parkinsonian disorders, and dementias. , 2000, Advances in neurology.
[144] H. Braak,et al. Sequence of Abeta-protein deposition in the human medial temporal lobe. , 2000, Journal of neuropathology and experimental neurology.
[145] V. Hachinski,et al. Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. , 2000, Neurology.
[146] J. Vanneste,et al. Diagnosis and management of normal-pressure hydrocephalus , 2000, Journal of Neurology.
[147] J. Finsterer,et al. Hypothyroid Myopathy with Unusually High Serum Creatine Kinase Values , 2000, Hormone Research in Paediatrics.
[148] NMR microscopy--beginnings and new directions. , 1999 .
[149] M. Bobinski,et al. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease , 1999, Neuroscience.
[150] A. Lang,et al. Dementia as the most common presentation of cortical-basal ganglionic degeneration , 1999, Neurology.
[151] D. Le Bihan,et al. Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI. , 1999, Stroke.
[152] G A Johnson,et al. Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[153] B. Winblad,et al. Assessing the societal impact of acetylcholinesterase inhibitor therapies. , 1999, Alzheimer Disease and Associated Disorders.
[154] Charles D. Smith,et al. Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease. , 1999, Neurology.
[155] R N Kalaria,et al. Overlap between pathology of Alzheimer disease and vascular dementia. , 1999, Alzheimer disease and associated disorders.
[156] Zsuzsanna Nagy,et al. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease , 1999, The Lancet.
[157] R. Faber,et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.
[158] J. Brandt,et al. Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease. , 1999, Brain : a journal of neurology.
[159] D. Radice,et al. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy , 1999, Neurology.
[160] Philip Scheltens,et al. Visual assessment of medial temporal lobe atrophy in demented and healthy control subjects: correlation with volumetry , 1999, Psychiatry Research: Neuroimaging.
[161] Linda Teri,et al. Clinico‐Neuropathological Correlation of Alzheimer's Disease in a Community‐Based Case Series , 1999, Journal of the American Geriatrics Society.
[162] S. Shimizu,et al. Dural arteriovenous malformation manifesting as dementia due to ischemia in bilateral thalami. A case report. , 1999, Surgical neurology.
[163] C. Jack,et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.
[164] I G McKeith,et al. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies , 1999, Neurology.
[165] P Kapeller,et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. , 1999, AJNR. American journal of neuroradiology.
[166] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .
[167] R. Edelman,et al. Diffusion-Weighted Magnetic Resonance Imaging in Alzheimer’s Disease , 1999, Dementia and Geriatric Cognitive Disorders.
[168] P. Lantos,et al. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies , 1999, British Journal of Psychiatry.
[169] I Litvan,et al. Consensus statement on the diagnosis of multiple system atrophy , 1998, Journal of the Neurological Sciences.
[170] P. Scheltens,et al. Vascular dementia: the role of cerebral infarcts. , 1999, Alzheimer disease and associated disorders.
[171] Vascular factors and Alzheimer disease. , 1999, Alzheimer disease and associated disorders.
[172] N. Mai,et al. Characteristic MR lesion pattern and correlation of T1 and T2 lesion volume with neurologic and neuropsychological findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). , 1999, AJNR. American journal of neuroradiology.
[173] H. Soininen,et al. Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. , 1999, AJNR. American journal of neuroradiology.
[174] F. Pasquier,et al. Medial temporal lobe atrophy in stroke patients: relation to pre-existing dementia , 1998, Journal of neurology, neurosurgery, and psychiatry.
[175] C. Jack,et al. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease , 1998, Neurology.
[176] P F Renshaw,et al. Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine. , 1998, AJNR. American journal of neuroradiology.
[177] A. Smith,et al. Comparison of Pathological Diagnostic Criteria for Alzheimer Disease , 1998, Alzheimer disease and associated disorders.
[178] R Brookmeyer,et al. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.
[179] J. Trojanowski,et al. Dementia resulting from dural arteriovenous fistulas: the pathologic findings of venous hypertensive encephalopathy. , 1998, AJNR. American journal of neuroradiology.
[180] Changiz Geula,et al. Abnormalities of neural circuitry in Alzheimer's disease , 1998, Neurology.
[181] R. Mohs,et al. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease , 1998, Neurology.
[182] B L Holman,et al. Preclinical prediction of Alzheimer's disease using SPECT , 1998, Neurology.
[183] K. Krishnan,et al. Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy , 1998, Psychiatry Research: Neuroimaging.
[184] H. Hanyu,et al. Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease , 1998, Journal of the Neurological Sciences.
[185] G. Fein,et al. Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain. , 1998, Radiology.
[186] H J Testa,et al. A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia? , 1998, Journal of neurology, neurosurgery, and psychiatry.
[187] A D Roses,et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. , 1998, The New England journal of medicine.
[188] H. Bokura,et al. Distinguishing silent lacunar infarction from enlarged Virchow-Robin spaces: a magnetic resonance imaging and pathological study , 1998, Journal of Neurology.
[189] F Barkhof,et al. Cine phase-contrast MR imaging in normal pressure hydrocephalus patients: relation to surgical outcome. , 1998, Acta neurochirurgica. Supplement.
[190] H. Braak,et al. Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria , 1998, Journal of Neural Transmission.
[191] G. Fein,et al. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease , 1997, Neurology.
[192] D. Leys,et al. Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome. , 1997, Stroke.
[193] K. Jellinger. Clinical-neuropathologic findings in multi-infarct dementia: A report of six autopsied cases , 1997, Neurology.
[194] Mari Yoshida,et al. Relationship between brainstem MRI and pathological findings in progressive supranuclear palsy — study in autopsy cases , 1997, Journal of the Neurological Sciences.
[195] J T O'Brien,et al. Temporal lobe magnetic resonance imaging can differentiate Alzheimer's disease from normal ageing, depression, vascular dementia and other causes of cognitive impairment , 1997, Psychological Medicine.
[196] G. Comi,et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. , 1997, Brain : a journal of neurology.
[197] S H Ferris,et al. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. , 1997, JAMA.
[198] C. Jack,et al. Hippocampal transverse relaxation times in patients with Alzheimer disease. , 1997, Radiology.
[199] J. Morris,et al. Current concepts in the pathogenesis of Alzheimer's disease. , 1997, The American journal of medicine.
[200] V. Hachinski,et al. Cerebrovascular Pathology in Alzheimer's Disease: Cause, Effect or Epiphenomenon? , 1997, Annals of the New York Academy of Sciences.
[201] H. Fukuyama,et al. Cerebral glucose metabolism in corticobasal degeneration: Comparison with progressive supranuclear palsy and normal controls , 1997, Movement disorders : official journal of the Movement Disorder Society.
[202] P. Mcgeer,et al. Familial nature and continuing morbidity of the amyotrophic lateral sclerosis-parkinsonism dementia complex of Guam , 1997, Neurology.
[203] T. Yanagihara,et al. Imaging in primary progressive aphasia , 1997, Neuroradiology.
[204] G C Roman,et al. Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.
[205] John Q. Trojanowski,et al. Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.
[206] M. Bobinski,et al. Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.
[207] Janice E Graham,et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population , 1997, The Lancet.
[208] T Ernst,et al. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. , 1997, Radiology.
[209] F Barkhof,et al. The Diagnostic Value of Magnetic Resonance Imaging and Technetium 99m‐HMPAO Single‐Photon-Emission Computed Tomography for the Diagnosis of Alzheimer Disease in a Community‐Dwelling Elderly Population , 1997, Alzheimer disease and associated disorders.
[210] John Hardy,et al. Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.
[211] H. Fukuyama,et al. Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy , 1997, Annals of neurology.
[212] W. Markesbery,et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.
[213] Florence Pasquier,et al. Why are stroke patients prone to develop dementia? , 1997, Journal of Neurology.
[214] A. Smith,et al. The Effects of Additional Pathology on the Cognitive Deficit in Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.
[215] J. P. Brandel,et al. Accuracy of the Clinical Diagnosis of Corticobasal Degeneration , 1997, Neurology.
[216] H. Braak,et al. Staging of Alzheimer-related cortical destruction. , 1997, International psychogeriatrics.
[217] G A Johnson,et al. Magnetic resonance microscopy of embryos. , 1996, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.
[218] J R Hodges,et al. Nonfluent progressive aphasia and semantic dementia: A comparative neuropsychological study , 1996, Journal of the International Neuropsychological Society.
[219] T. Jones,et al. Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease , 1996, The Lancet.
[220] L. Fried,et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. , 1996, Stroke.
[221] M. Pericak-Vance,et al. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease , 1996, The Lancet.
[222] M. Hallett,et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.
[223] Sandra E. Black,et al. Focal Cortical Atrophy Syndromes , 1996, Brain and Cognition.
[224] H. Soininen,et al. MR T2 relaxometry in Alzheimer's disease and age-associated memory impairment , 1996, Neurobiology of Aging.
[225] S. Finklestein,et al. Petechial hemorrhages accompanying lobar hemorrhage , 1996, Neurology.
[226] I. Zerr,et al. MR imaging of Creutzfeldt-Jakob disease. , 1996, Radiology.
[227] H. Soininen,et al. Severity of hippocampal atrophy correlates with the prolongation of MRI T sub 2 relaxation time in temporal lobe epilepsy but not in Alzheimer's disease , 1996, Neurology.
[228] H. Braak,et al. Age, neurofibrillary changes, Aβ-amyloid and the onset of Alzheimer's disease , 1996, Neuroscience Letters.
[229] J. Pettegrew,et al. Quantitative 1H and 31P MRS of PCA extracts of postmortem Alzheimer's disease brain , 1996, Neurobiology of Aging.
[230] G. Frisoni,et al. Linear measures of atrophy in mild Alzheimer disease. , 1996, AJNR. American journal of neuroradiology.
[231] V Hachinski,et al. Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia. , 1996, Archives of neurology.
[232] H. Soininen,et al. Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia , 1996, Neurology.
[233] F. Fazekas,et al. MR of cerebral abnormalities concomitant with primary intracerebral hematomas. , 1996, AJNR. American journal of neuroradiology.
[234] W G Bradley,et al. Normal-pressure hydrocephalus: evaluation with cerebrospinal fluid flow measurements at MR imaging. , 1996, Radiology.
[235] D. Dickson,et al. Neuropathologic Overlap of Progressive Supranuclear Palsy, Pick's Disease and Corticobasal Degeneration , 1996, Journal of neuropathology and experimental neurology.
[236] H. Braak,et al. Age, neurofibrillary changes, A beta-amyloid and the onset of Alzheimer's disease. , 1996, Neuroscience letters.
[237] Chickering Jg,et al. Innervation of propatagial musculature in a flying squirrel, Glaucomys volans (Rodentia, Sciuridae). , 1996 .
[238] K. Jellinger,et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. , 1996, Neurology.
[239] M. Hutchinson,et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: MR findings. , 1995, AJNR. American journal of neuroradiology.
[240] H. Tohgi,et al. MR anatomy of the substantia innominata and findings in Alzheimer disease: a preliminary report. , 1995, AJNR. American journal of neuroradiology.
[241] E F Halpern,et al. Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18. , 1995, AJNR. American journal of neuroradiology.
[242] O L Lopez,et al. Computed tomography--but not magnetic resonance imaging--identified periventricular white-matter lesions predict symptomatic cerebrovascular disease in probable Alzheimer's disease. , 1995, Archives of neurology.
[243] H. Braak,et al. Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.
[244] B D Ross,et al. Probable Alzheimer disease: diagnosis with proton MR spectroscopy. , 1995, Radiology.
[245] M. Gearing,et al. The CERAD experience, part VIII , 1995, Neurology.
[246] C. Loeb. Dementia due to lacunar infarctions: a misnomer or a clinical entity? , 1995, European neurology.
[247] R. Steen,et al. Age‐related changes in proton T1 values of normal human brain , 1995, Journal of magnetic resonance imaging : JMRI.
[248] H. Groenewegen,et al. Anthony H.M. Lohman: reflections on a distinguished career in anatomy. , 1995, Brain, behavior and evolution.
[249] O. Henriksen,et al. Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease. , 1995, Magnetic resonance imaging.
[250] J. O'Brien,et al. Volumetric and visual assessment of the mesial temporal structures in Alzheimer's disease. , 1994, Australian and New Zealand journal of medicine.
[251] T. Ernst,et al. Abnormal cerebral metabolite concentrations in patients with probable alzheimer disease , 1994, Magnetic resonance in medicine.
[252] A. Hofman,et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population‐based study , 1994, Neurology.
[253] Bertil Olsson,et al. Cerebral Lesions on Magnetic Resonance Imaging, Heart Disease, and Vascular Risk Factors in Subjects Without Stroke: A Population‐Based Study , 1994, Stroke.
[254] Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[255] D. Benson,et al. Posterior Cortical Atrophy: Neuropathologic Correlations , 1994 .
[256] R I Grossman,et al. Magnetization transfer: theory and clinical applications in neuroradiology. , 1994, Radiographics : a review publication of the Radiological Society of North America, Inc.
[257] D Comar,et al. Differential diagnosis of Alzheimer's disease with PET. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[258] M Kouwenhoven,et al. Phase-Contrast Cine Mr Imaging of Normal Aqueductal CSF Flow , 1994, Acta radiologica.
[259] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[260] H. Eiberg,et al. Linkage studies of cholestasis familiaris groenlandica/Byler-like disease with polymorphic protein and blood group markers. , 1993, Human heredity.
[261] B D Ross,et al. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. , 1993, Radiology.
[262] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[263] A. Smith,et al. Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography , 1992, The Lancet.
[264] J. Growdon,et al. Treatment for Alzheimer's disease? , 1992, The New England journal of medicine.
[265] P. Scheltens,et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[266] P. Scheltens,et al. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. , 1992, Brain : a journal of neurology.
[267] B L Miller,et al. Neuropsychological correlates of white-matter lesions in healthy elderly subjects. A threshold effect. , 1992, Archives of neurology.
[268] Donald S. Williams,et al. Magnetic resonance imaging of perfusion using spin inversion of arterial water , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[269] G D Pearlson,et al. Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. , 1992, Archives of general psychiatry.
[270] P. Anslow,et al. Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[271] J. Besson,et al. Post-mortem Proton Magnetic Resonance Spectrometric Measures of Brain Regions in Patients with a Pathological Diagnosis of Alzheimer's Disease and Multi-infarct Dementia , 1992, British Journal of Psychiatry.
[272] Larry L. Butcher,et al. Prolongation of magnetic resonance T 2 time in hippocampus of human patients marks the presence and severity of Alzheimer's disease , 1992, Neuroscience Letters.
[273] C. Jack,et al. MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease , 1992, Neurology.
[274] P. Ince,et al. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: Comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients , 1991, Journal of the Neurological Sciences.
[275] F. Fazekas,et al. The morphologic correlate of incidental punctate white matter hyperintensities on MR images. , 1991, AJNR. American journal of neuroradiology.
[276] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[277] W G Bradley,et al. Marked cerebrospinal fluid void: indicator of successful shunt in patients with suspected normal-pressure hydrocephalus. , 1991, Radiology.
[278] D. Le Bihan. Molecular diffusion nuclear magnetic resonance imaging. , 1991, Magnetic resonance quarterly.
[279] D. Munoz. The pathological basis of multi-infarct dementia. , 1991, Alzheimer disease and associated disorders.
[280] W. Bradley,et al. Association of deep white matter infarction with chronic communicating hydrocephalus: implications regarding the possible origin of normal-pressure hydrocephalus. , 1991, AJNR. American journal of neuroradiology.
[281] D. Tank,et al. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[282] S. Ogawa. Brain magnetic resonance imaging with contrast-dependent oxygenation , 1990 .
[283] M. Albert,et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. , 1989, JAMA.
[284] G. Paulson,et al. Magnetic resonance imaging in dementia of Parkinson's disease. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[285] Gwenn S. Smith,et al. EARLY MARKER FOR ALZHEIMER'S DISEASE: THE ATROPHIC HIPPOCAMPUS , 1989, The Lancet.
[286] H. Braak,et al. Alzheimer's disease: Mismatch between amyloid plaques and neuritic plaques , 1989, Neuroscience Letters.
[287] P Soliveri,et al. MR Imaging in Progressive Supranuclear Palsy and Shy‐Drager Syndrome , 1989, Journal of computer assisted tomography.
[288] N. Quinn,et al. Multiple system atrophy--the nature of the beast. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[289] M. LeMay,et al. Temporal lobe atrophy in patients with Alzheimer disease: a CT study. , 1989, AJNR. American journal of neuroradiology.
[290] R. Balaban,et al. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo , 1989, Magnetic resonance in medicine.
[291] D. Knopman,et al. The spectrum of imaging and neuropsychological findings in Pick's disease , 1989, Neurology.
[292] S. Rosini,et al. Effects of diacerein on the quantity and phagocytic activity of thioglycollate-elicited mouse peritoneal macrophages. , 1989, Pharmacology.
[293] J. Harrison,et al. Posterior cortical atrophy. , 1989, Clinical and experimental neurology.
[294] W. Jagust,et al. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease , 1988, Magnetic resonance in medicine.
[295] J. Pettegrew,et al. Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer's disease. , 1988, Archives of neurology.
[296] J. Trojanowski,et al. Brain MR: pathologic correlation with gross and histopathology. 1. Lacunar infarction and Virchow-Robin spaces. , 1988, AJR. American journal of roentgenology.
[297] J. Pettegrew,et al. 31P Nuclear Magnetic Resonance Study of the Brain in Alzheimer's Disease , 1988, Journal of neuropathology and experimental neurology.
[298] B. Drayer,et al. Imaging of the aging brain. Part II. Pathologic conditions. , 1988, Radiology.
[299] M Haupt,et al. [Clinical diagnosis of Alzheimer's disease]. , 1988, Deutsche medizinische Wochenschrift.
[300] A. Alavi,et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.
[301] M. Tierney,et al. The Differential Diagnosis of Alzheimer's Disease: Conceptual and Methodological Issues , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[302] R F Spetzler,et al. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. , 1986, Stroke.
[303] W. Bradley,et al. Flowing cerebrospinal fluid in normal and hydrocephalic states: appearance on MR images. , 1986, Radiology.
[304] J. Vanneste,et al. Non-tumoural aqueduct stenosis and normal pressure hydrocephalus in the elderly. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[305] C. Derouesné,et al. [The concept of cerebral lacunae from 1838 to the present]. , 1985, Revue neurologique.
[306] C. Derouesné,et al. Cerebral lacunae. A proposed new classification. , 1984, Clinical neuropathology.
[307] C. Fisher. Lacunar strokes and infarcts , 1982, Neurology.
[308] J. Coyle,et al. Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis , 1981, Annals of neurology.
[309] D. Davies,et al. MYOCARDIAL DISORDERS IN THE ELDERLY. , 1963, Lancet.
[310] R. Webster. Magnetic Resonance Spectroscopy , 1962, Nature.
[311] J. W. Papez. A PROPOSED MECHANISM OF EMOTION , 1937 .
[312] A. Nappi,et al. Alzheimer ' s Disease : Cell-Specific Pathology Isolates the Hippocampal Formation , 2022 .